A detailed history of Ieq Capital, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 26,558 shares of HRMY stock, worth $903,768. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,558
Previous 9,420 181.93%
Holding current value
$903,768
Previous $297,000 146.13%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$26.76 - $38.05 $458,612 - $652,100
17,138 Added 181.93%
26,558 $731,000
Q2 2025

Aug 14, 2025

BUY
$27.94 - $35.91 $93,235 - $119,831
3,337 Added 54.86%
9,420 $297,000
Q1 2025

May 14, 2025

BUY
$32.18 - $40.46 $195,750 - $246,118
6,083 New
6,083 $201,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.